DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Cytokinetics, Incorporated (CYTK)
« Back to company indexCYTK Chatter Timeline
Stock Ticker for CYTK
Most Active Tweeters for CYTK
No tweets foundRecent Tweets for CYTK
 |
@MareaInformativ -$0.48 Earnings Per Share Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/0tQboK4Yz3 August 21st 2018, 8:08am |
 |
@TranscriptDaily Cytokinetics, Inc. $CYTK Receives $14.50 Consensus Price Target from Brokerages https://t.co/uyenm0CxRW August 20th 2018, 12:08pm |
 |
@registrarjourn Cytokinetics, Inc. $CYTK Receives $15.63 Average PT from Analysts https://t.co/zFfuje20Pk August 20th 2018, 12:08pm |
|
@registrarjourn Cytokinetics $CYTK Releases Quarterly Earnings Results, Hits Expectations https://t.co/taSrywStZb August 19th 2018, 6:08am |
|
@MareaInformativ Cytokinetics $CYTK Getting Somewhat Favorable Press Coverage, Study Shows https://t.co/b8V29KhFyz August 18th 2018, 11:08pm |
 |
@ChartMill A Current Ratio of 8.95 indicates that $CYTK has no problem at all paying its short term obligations.… https://t.co/a1YroPa4kD August 17th 2018, 6:08pm |
|
@MareaInformativ Cytokinetics $CYTK Upgraded at BidaskClub https://t.co/Npliioz1tV August 17th 2018, 6:08pm |
 |
@beyond_ninety Atlantic Equities Upgrades First Data $FDC; Cytokinetics $CYTK Sentiment Is 0.88 https://t.co/ExDLPnleTi August 17th 2018, 10:08am |
 |
@OlympiaReport Cytokinetics, Inc. $CYTK Receives Consensus Recommendation of “Hold” from Analysts https://t.co/btTPF0fGKB August 15th 2018, 4:08pm |
 |
@AmericanBanking Cytokinetics, Inc. $CYTK Receives Average Rating of “Hold” from Analysts https://t.co/xnRzFmp9uZ #stocks August 15th 2018, 2:08pm |
 |
@dispatchtribune Cytokinetics, Inc. $CYTK Receives Average Rating of “Hold” from Analysts https://t.co/XjB1u8cG9s August 15th 2018, 2:08pm |
|
@AmericanBanking Cytokinetics $CYTK – Investment Analysts’ Recent Ratings Updates https://t.co/bJziwGYIVN #stocks August 13th 2018, 4:08pm |
|
@MareaInformativ Cytokinetics $CYTK – Investment Analysts’ Recent Ratings Updates https://t.co/2kSNjM71O4 August 13th 2018, 4:08pm |
 |
@WatchlistN Cytokinetics $CYTK – Investment Analysts’ Recent Ratings Updates https://t.co/K7gJ6AJW5U August 13th 2018, 4:08pm |
|
@MareaInformativ Cytokinetics $CYTK Downgraded to Hold at BidaskClub https://t.co/QBaP21JpdI August 13th 2018, 2:08am |
 |
@ZolmaxNews Cytokinetics $CYTK Raised to “Hold” at BidaskClub https://t.co/hOIjnYuWfh August 13th 2018, 1:08am |
|
@OlympiaReport Cytokinetics, Inc. $CYTK Expected to Announce Earnings of -$0.48 Per Share https://t.co/TEN2w0dAgZ August 12th 2018, 4:08pm |
|
@dispatchtribune Zacks: Brokerages Expect Cytokinetics, Inc. $CYTK Will Announce Earnings of -$0.48 Per Share https://t.co/WnNUNPvxwu August 12th 2018, 4:08pm |
 |
@WeekHerald $2.52 Million in Sales Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/GQcPgHsOJW August 12th 2018, 4:08pm |
 |
@ThisLincolnian Cytokinetics, Inc. $CYTK Expected to Announce Quarterly Sales of $2.52 Million https://t.co/pC4Ho4c5ou August 12th 2018, 4:08pm |
 |
@EnterpriseLeade Cytokinetics $CYTK Given a $24.00 Price Target at HC Wainwright https://t.co/TCfN78xQZI August 12th 2018, 1:08pm |
|
@MareaInformativ Cytokinetics $CYTK Given a $24.00 Price Target at HC Wainwright https://t.co/oylwd9zGPu August 12th 2018, 1:08pm |
|
@ThisLincolnian Cytokinetics $CYTK Lifted to “Hold” at BidaskClub https://t.co/b878WTKpuy August 12th 2018, 1:08pm |
|
@EnterpriseLeade Cytokinetics $CYTK Cut to “Hold” at BidaskClub https://t.co/3Kn5r3tfwN August 12th 2018, 12:08am |
|
@MareaInformativ Cytokinetics $CYTK Downgraded by Morgan Stanley to Equal Weight https://t.co/HxU4dKGd10 August 11th 2018, 3:08pm |
|
@EnterpriseLeade Cytokinetics $CYTK Releases Earnings Results, Hits Estimates https://t.co/8aqKnR7ve3 August 11th 2018, 12:08pm |
 |
@TickerReport BidaskClub Upgrades Cytokinetics $CYTK to “Hold” https://t.co/LpkBeDOnOF August 11th 2018, 12:08pm |
|
@beyond_ninety Cytokinetics $CYTK Shareholder Citigroup Has Trimmed Its Stake as Stock Rose; Varonis Systems $VRNS Holder Emerald… https://t.co/m6m9alKmAG August 11th 2018, 7:08am |
|
@OlympiaReport BidaskClub Upgrades Cytokinetics $CYTK to “Hold” https://t.co/pMxcwR0oP9 August 10th 2018, 6:08pm |
|
@dispatchtribune Cytokinetics $CYTK Upgraded to “Hold” at BidaskClub https://t.co/KmDcYLxeka August 10th 2018, 6:08pm |
|
@TranscriptDaily -$0.48 Earnings Per Share Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/2qxcSFqGvm August 10th 2018, 6:08pm |
|
@EnterpriseLeade Cytokinetics, Inc. $CYTK Expected to Announce Quarterly Sales of $2.52 Million https://t.co/YCXYXWKsIp August 10th 2018, 9:08am |
 |
@dakotafinancial Cytokinetics $CYTK Upgraded to “Hold” by BidaskClub https://t.co/lJkK26iUgk August 9th 2018, 3:08am |
|
@ZolmaxNews Cytokinetics, Inc. $CYTK Expected to Announce Earnings of -$0.48 Per Share https://t.co/QwpY4s3xGW August 8th 2018, 10:08am |
 |
@ConsumerFeed Robert I. Blum Sells 4,000 Shares of Cytokinetics, Inc. $CYTK Stock https://t.co/hNTiDSqdl0 August 8th 2018, 3:08am |
|
@TranscriptDaily Cytokinetics $CYTK Downgraded to “Sell” at ValuEngine https://t.co/qYwITPPCxW August 8th 2018, 2:08am |
|
@ConsumerFeed Cytokinetics, Inc. $CYTK Expected to Announce Quarterly Sales of $2.52 Million https://t.co/a8ozoChxGo August 8th 2018, 2:08am |
|
@AmericanBanking Cytokinetics, Inc. $CYTK Expected to Announce Quarterly Sales of $2.52 Million https://t.co/RSrGminsvo #stocks August 8th 2018, 2:08am |
|
@EnterpriseLeade Zacks Investment Research Upgrades Cytokinetics $CYTK to “Buy” https://t.co/eIPoxd8PcV August 7th 2018, 6:08pm |
 |
@trumptrackerbot $CYTK - 10-Q - At the federal level, the Trump administrations budget proposal for fiscal year 2019 contains furthe… https://t.co/y2uO9KTdmQ August 7th 2018, 5:08pm |
|
@trumptrackerbot $CYTK - 10-Q - Since its enactment, there have been judicial and Congressional challenges to numerous provisions of… https://t.co/v4vc3AuBFF August 7th 2018, 5:08pm |
|
@trumptrackerbot $CYTK - 10-Q - Additionally, on January 22, 2018, President Trump signed a continuing resolution on appropriations… https://t.co/4Li6vxRddz August 7th 2018, 5:08pm |
 |
@Allstocknews $CYTK New Form 10-Q for Cytokinetics Inc From our Stock News Alerts App August 7th 2018, 5:08pm |
 |
@TheMarketsDaily Cytokinetics $CYTK Rating Lowered to Sell at BidaskClub https://t.co/Ine7R64fbl August 7th 2018, 12:08pm |
|
@ConsumerFeed Insider Selling: Cytokinetics, Inc. $CYTK CEO Sells 4,000 Shares of Stock https://t.co/aNN2MKQusW August 7th 2018, 10:08am |
|
@MareaInformativ Cytokinetics, Inc. $CYTK Expected to Announce Quarterly Sales of $2.52 Million https://t.co/AzWQbAU5fF August 7th 2018, 6:08am |
|
@TheMarketsDaily -$0.48 Earnings Per Share Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/FCX1PLareN August 7th 2018, 5:08am |
|
@ConsumerFeed Insider Selling: Cytokinetics, Inc. $CYTK EVP Sells 1,500 Shares of Stock https://t.co/rkAAqZ1t5a August 6th 2018, 4:08pm |
|
@AmericanBanking -$0.48 Earnings Per Share Expected for Cytokinetics, Inc. $CYTK This Quarter https://t.co/Oap3a79W5b #stocks August 6th 2018, 4:08pm |
|
@dakotafinancial Cytokinetics $CYTK Downgraded by ValuEngine to “Sell” https://t.co/DOB5bfA34y August 6th 2018, 9:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.